Scientists test new oral combo against tough cancers
NCT ID NCT01534598
Summary
This early-stage trial tested whether two experimental drugs, FdCyd and THU, could be safely given as pills to people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find the highest dose patients could tolerate without severe side effects. Researchers also wanted to see if this oral combination showed any signs of slowing cancer growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
-
Penn State
Hershey, Pennsylvania, 17033, United States
-
UC Davis Cancer Center
Sacramento, California, 95817, United States
-
USC Norris Cancer Center
Los Angeles, California, 90033, United States
-
University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, 15232, United States
Conditions
Explore the condition pages connected to this study.